These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6642784)

  • 1. In vitro drug metabolism in humans with different liver diseases.
    Narang AP; Datta DV; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):496-8. PubMed ID: 6642784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of mixed function oxidases, UDP-glucuronyl transferase and sulphate conjugation enzymes in galliformes and anseriformes.
    Bartlet AL; Kirinya LM
    Q J Exp Physiol Cogn Med Sci; 1976 Apr; 61(2):105-19. PubMed ID: 819957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipyrine clearance, aminopyrine N-demethylase, and bilirubin UDP-glucuronyl transferase activity in patients with amoebic liver abscess.
    Narang AP; Datta DV; Mathur VS
    Biopharm Drug Dispos; 1982; 3(1):39-45. PubMed ID: 7082778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of hepatic bilirubin UDP-glucuronyl transferase in patients with noncirrhotic portal fibrosis and liver disease: Significance and limitations.
    Datta DV; Nair R; Nair CR
    Am J Dig Dis; 1975 Oct; 20(10):961-7. PubMed ID: 811112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro drug metabolism in patients with leprosy.
    Kumar B; Narang AP; Koshy A; Sharma SC; Kaur S
    Lepr India; 1982 Jan; 54(1):75-81. PubMed ID: 6808244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of drug elimination in patients with liver disease.
    Narang AP; Datta DV; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplicity and specificity of UDP-glucuronyl transferase. 3. UDP-glucuronyl transferase and -glucuronidase activities assayed with different substrates in inherited and acquired human liver diseases.
    Okolicsanyi L; Frei J; Magnenat P; Naccarato R
    Enzyme; 1971; 12(6):658-73. PubMed ID: 5154445
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of human liver bilirubin-glycosyl transferase. Bilirubin UDP-xylosyl and UDP-glucuronyl transferase activities in diseased human livers.
    Motoyama Y
    Enzyme; 1979; 24(3):158-62. PubMed ID: 115686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence and induction of drug metabolizing enzymes in rat bone marrow.
    Dresner JH; Ibrahim NG; Levere RD
    Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):281-98. PubMed ID: 6787676
    [No Abstract]   [Full Text] [Related]  

  • 10. Tyramine oxidase activity in needle biopsy of normal livers and diseased livers.
    Arima T; Okada Y; Kubota M; Nagata K; Higuchi Y
    Enzyme; 1977; 22(2):124-9. PubMed ID: 15828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental hepatic injury: the sequential changes in drug metabolizing enzyme activities after administration of acetaminophen.
    Willson RA; Hart FE
    Res Commun Chem Pathol Pharmacol; 1977 Jan; 16(1):59-71. PubMed ID: 402686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of fascioliasis on the activities of some drug-metabolizing enzymes in desert sheep liver.
    Elsheikh HA; Ali BH; Homeida AM; Lutfi AA; Hapke HJ
    Br Vet J; 1992; 148(3):249-57. PubMed ID: 1617399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of hepatic drug metabolism in patients with acute viral hepatitis.
    Narang AP; Datta DV; Nath N; Mathur VS
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):255-8. PubMed ID: 7166177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of n-hexane treatment on the glucuronic acid pathway and activity of some drug-metabolizing enzymes in guinea-pig.
    Notten WR; Henderson PT
    Biochem Pharmacol; 1975 Jan; 24(1):127-31. PubMed ID: 804901
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of vitamin A deficiency on hepatic and intestinal drug metabolizing enzymes in rats.
    Gupta PH; Mehta S; Mehta SK
    Biochem Int; 1989 Jul; 19(1):123-33. PubMed ID: 2505773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitragyna speciosa Korth leaves extracts induced the CYP450 catalyzed aminopyrine-N-demethylase (APND) and UDP-glucuronosyl transferase (UGT) activities in male Sprague-Dawley rat livers.
    Azizi J; Ismail S; Mansor SM
    Drug Metabol Drug Interact; 2013; 28(2):95-105. PubMed ID: 23435185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes in female rats; changes in liver microsomal aminopyrine N-demethylase and UDP-glucuronyl transferase activities.
    Del Villar E; Vega P; Gaule C; Sanchez E
    Eur J Drug Metab Pharmacokinet; 1990; 15(4):279-85. PubMed ID: 2128478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug metabolism in non-cirrhotic portal fibrosis and other liver diseases.
    Narang AP; Mathur VS; Koshy A; Nath N; Datta DV
    Indian J Med Res; 1981 Aug; 74():266-72. PubMed ID: 6796511
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatic bilirubin UDP-glucuronyl transferase activity and cytochrome P450 content in a surgical population, and the effects of preoperative drug therapy.
    Black M; Perrett RD; Carter AE
    J Lab Clin Med; 1973 May; 81(5):704-12. PubMed ID: 4698657
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of in vitro drug metabolism by lung, liver, and kidney of several common laboratory species.
    Litterst CL; Mimnaugh EG; Reagan RL; Gram TE
    Drug Metab Dispos; 1975; 3(4):259-65. PubMed ID: 240655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.